Publication | Closed Access

Maintained Reduction of Intraocular Pressure by Prostaglandin F2α-1-Isopropyl Ester Applied in Multiple Doses in Ocular Hypertensive and Glaucoma Patients

HypertensionOcular DiseaseOphthalmologyIntraocular PressureMedicineEndocrinologyPharmacotherapyGlaucomaOcular Surface PhysiologyOcular PharmacologyPharmacologyGlaucoma PatientsOcular Hypertensive